Apalutamide
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 717 publications
Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide.
Journal: Journal of comparative effectiveness research
Published: January 16, 2026
Antiandrogen therapies: Management of drug interactions with anticoagulation.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: December 23, 2025
Long-term trends in androgen-directed therapy in advanced prostate cancer: a 29-year national analysis.
Journal: International urology and nephrology
Published: December 12, 2025
Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial.
Journal: Japanese journal of clinical oncology
Published: November 13, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.
Journal: JCO oncology practice
Published: November 07, 2025
De novo small cell neuroendocrine carcinoma of the prostate with extremely elevated PSA and Gleason score 5 + 5: a case report.
Journal: Frontiers in oncology
Published: November 06, 2025
Prostate cancer progression: a scoping review, pharmacoeconomic assessment, and evaluation of quality of life.
Journal: Journal of medical economics
Published: October 23, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter study.
Journal: Japanese journal of clinical oncology
Published: October 22, 2025
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes.
Journal: The French journal of urology
Published: October 06, 2025
Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone Acetate.
Journal: Journal of health economics and outcomes research
Published: October 02, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).
Journal: European urology oncology
Published: September 29, 2025
Multidisciplinary therapy targeting histological heterogeneity in prostate cancer with bone marrow carcinomatosis: A case report.
Journal: Urology case reports
Published: September 27, 2025
Last Updated: 02/24/2026